Title : Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab.

Pub. Date : 2021 Jan-Dec

PMID : 33948533






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background and purpose: Randomised-controlled clinical trials (the ANCHOR and MARINA) examined the intravitreal anti-vascular endothelial growth factor (anti-VEGF) efficacy for eyes having fluorescein angiographic classic and occult (OCC) neovascular lesions. Fluorescein vascular endothelial growth factor A Homo sapiens
2 Background and purpose: Randomised-controlled clinical trials (the ANCHOR and MARINA) examined the intravitreal anti-vascular endothelial growth factor (anti-VEGF) efficacy for eyes having fluorescein angiographic classic and occult (OCC) neovascular lesions. Fluorescein vascular endothelial growth factor A Homo sapiens